Aminoglycoside-modifying enzymes are commonly found to be the cause of bacterial resistance to aminoglycosides. They are classified according to their mode of modification as phosphoryltransferases (APHs), nucleotidyltransferases (ANTs), or acetyltransferases (AACs).
Eight isoenzymes of the 3-N-acetyltransferase have been reported to date: aminoglycoside-(3)-N-acetyltransferase I [AAC(3)-I], -Ia, -II, -III, -IV, -V, -VI, and -VII (23) . These enzymes modify the same amino group within the aminoglycoside molecule but differ in their substrate specificities.
The AAC(3)-III enzyme has been found thus far only in Pseudomonas spp. (4, 7, 16) . The nucleotide sequence of a putative AAC(3)-III-coding gene (aacC3) has been reported by Allmansberger et al. (1) . However, this gene was obtained from a Klebsiella pneumoniae strain, and it appeared later to be the aacC5 gene (3) . Furthermore, the nUcleotide sequence of this gene appeared to be identical to that of aacC2 (23) , a gene commonly found among members of the family Enterobacteriaceae (12, 15, 23) .
AAC(3)-Ia is also confined to pseudomonads (16) and shows homology to the aacCl gene (22) . AAC(3)-VI has recently been detected in nine strains of gentamicin-resistant members of the family Enterobacteriaceae (18) , and AAC (3)-VII has been detected in Streptomyces rimosus forma paramomycinus (14) .
In this report we describe the cloning and sequencing of the chromosomal aacC3 gene of P. aeruginosa PST-I and the development and testing of a polymerase chain reaction (PCR) (24) to detect the aacC3 gene. * Corresponding author.
MATERIALS AND METHODS
Bacterial strains and plasmids. The bacterial strains and plasmids used in this study are listed in Table 1 . Fifty gentamicin-resistant pseudomonads obtained from several hospitals in The Netherlands were kindly provided by A. J.
de Neeling (National Institute of Public Health and Environmental Protection, Bilthoven, The Netherlands). The Escherichia coli KMBL5071 strain (6) is a derivative of strain P90C (17) carrying the F' factor of strain JM101 (19) . It was kindly provided by J. Brouwer (Laboratory of Molecular Genetics, State University, Leiden, The Netherlands) and was used as a host for bacteriophage M13mpl8 (19) .
The 23 reference strains used in this study that produced 12 different aminoglycoside-modifying enzymes are listed in Table 2 . Strains were obtained from J. Davies ( Preparation of cell-free lysates. Bacterial cells were grown for 18 h at 37°C (or 30°C in the case of Pseudomonas putida) in LB medium (19) containing gentamicin (10 ,ug/ml). Cellfree lysates were prepared by sonication as described previously (5) .
Identification of aminoglycoside-modifying enzymes. The substrate profile of the aminoglycoside-acetylating enzyme was determined by the phosphocellulose paper-binding radioassay (11) . Three concentrations (3 x 10-3, 1 X 10-2, and 3 x 10-2 mM) of each of the following aminoglycosides were used: amikacin, dibekacin, gentamicin, kanamycin, neomycin, netilmicin, sisomicin, and tobramycin. Reactions were incubated for 15 min at 37°C as described previously (5 Preparation of DNA. Total genomic DNA was isolated from a 10-ml culture by a Triton-lysozyme method (10) . The DNA thus obtained was suspended in 3 ml of TE buffer (10 mM Tris-HCl [pH 7 .5], 1 mM EDTA) containing proteinase K (50 ,ug/ml; Boehringer Mannheim) and incubated for 1 h at 37°C. Subsequently, phenol-chloroform extraction and alcohol precipitation were performed as described by Sambrook et al. (19) .
Plasmid DNA was prepared by an alkaline lysis method (19 The M13mpl8 subclones derived by the Erase-a-Base system were sequenced by the dideoxy-chain termination method described by Sanger et al. (20) . The TAQuence sequencing kit (United States Biochemical Corp.) and 7-deaza-dGTP were used to avoid band compressions.
[a-35S]dATP (>1,000 Ci/mmol; Amersham)-labeled fragments were separated on 8% polyacrylamide gels containing 8 M urea. The gels were fixed in 10% acetic acid-12% methanol for 15 min and dried at 80°C. They were exposed to X-ray film (Fuji RX) and autoradiographed at room temperature.
In vitro transcription-translation of DNA. In vitro transcription-translation of plasmid DNA was performed by using a procaryotic DNA-directed transcription-translation system (Amersham). The [35S]methionine (>1,000 Ci/mmol; Amersham)-labeled proteins were analyzed on a 12% polyacrylamide gel containing 0.1% sodium dodecyl sulfate, as described by Laemmli (13) . Prestained protein markers (Bio-Rad Laboratories) were included as references. Gels were fixed in 12% methanol-10% acetic acid and stained with Coomassie brilliant blue R-250. After drying at 80°C, the labeled protein bands were made visible by autoradiography.
PCR. Twenty-mer oligonucleotides to be used as aacC3-specific primers in the PCR were obtained from Pharmacia. The primer sequences were chosen to meet the following criteria: (i) no more than approximately 50% homology within a primer or between the downstream primer and the upstream primer; (ii) a G+C content of approximately 50% in each primer; and (iii) presence of a unique restriction site (BstEII) in the region to be amplified, to provide an additional Qpportunity to check the specificity of the PCR. The nucleotide sequences of the 16S rRNA primers were based on conserved regions of the 16S rRNA genes (rrs) of Mycobacterium bovis BCG, Streptomyces lividans, and E. coli and have been described previously (24). The isolation of total cellular DNA and the DNA amplification were performed as described previously (24). Samples of 10 jugants. The sizes of the deletions in the KpnI fragment were determined by digestion of the DNA with EcoRI and HindlIl. From these data we concluded that the length of the aacC3 locus was approximately 1,750 bp (Fig. 2) . Nucleotide sequence of the aacC3 gene and surroundings. The strategy used in the nucleotide sequencing of the aacC3 gene and its adjacent regions is shown in Fig. 2 
GTT AAA GCA GTG GGC GCG GTG ATG GGC GGC CCC AAT GTG ATC TTG CAG 1270 
CCG TGC GTG CAT CGC AGC GCA AAC CCC GAA GCC TCT ATG GTG GCG GTA 1510 TGG CTT GAA TCA CGG TTC GGT GAC TCA GCG TCA TAC GGA  3 GCG region, which included both a ribosome-binding site and the start codon of ORF-2.
In vitro transcription-translation. A DNA-dependent in vitro transcription-translation system, derived from E. coli, was used to study the proteins encoded by the 2. Identification of the aacC3 gene. The data collected in the experiments described above strongly suggest that the products of the two ORFs are translated from a single messenger and that ORF-2 codes for the AAC(3)-III enzyme.
PCR for the detection of the aacC3 gene. In a previous study (24), we described a method for the detection of three aacC genes (aacCl, aacC2, and aacC4) via PCR. Two rrs gene primers were used as a positive control for the PCR. In order to extend this method to the aacC3 gene, we chose two synthetic 20-mer oligonucleotide primers. These were based on the nucleotide sequence of the gene (Fig. 3) . The length of the amplified regions of the aacC3 gene (185 bp) and the rrs gene (approximately 325 bp) are shown in Fig. 5 . The result of the amplification reaction with total genomic DNA obtained from P. putida KT2440(pJV305) as a template is shown in Fig. 6 . A 185-bp fragment was generated, as expected (lane 3). Digestion by BstEII yielded two fragments of 124 and 61 bp (lane 4). The 330-bp amplified fragment of the rrs gene is seen both in the control strain (lane 2) and in the aacC3-containing strain (lanes 3 and 4) .
The specificities of the aacC3 primers were tested by using total genomic DNA obtained from 23 reference strains that produced 12 different aminoglycoside-modifying enzymes ( Table 2 ). The 16S rRNA-specific fragments were produced in all test mixtures. Only the reference strain that produced AAC(3)-III showed the aacC3-specific band of approximately 185 bp. Restriction analysis of the amplified DNA of this strain confirmed the identity of the fragment that was generated.
Fifty Until now, the aacC3 gene has only been found in Pseudomonas spp. (4, 7, 16) . When the plasmid containing the gene was transferred to E. coli HB101, no change in susceptibility to the eight aminoglycosides tested was detected. Analysis of the labeled proteins obtained from an E. colibased in vitro transcription-translation system showed translation only of the 23.9-kDa protein encoded by ORF-1, in comparison with translation of the proteins encoded by the vector plasmid. Furthermore, a deletion which removed the putative -35 region of ORF-1 prevented expression of aacC3 in the Pseudomonas strain bearing this plasmid. This indicates that AAC(3)-III is transcribed from a bicistronic messenger. Our results indicate that the promoter of the operon is active in E. coli. This implies that, in E. coli, either the mRNA is not completely synthesized or the initiation of translation of ORF-2 is obstructed. This may be due to the formation of a stem-loop structure in the intercistronic region, which includes both a ribosome-binding site and the start codon of ORF-2. Alternatively, we cannot rule out the presence of a positive regulatory factor for ORF-2 in pseudomonads. Experiments are under way to elucidate this problem.
The PCR distilled from our sequence data proved to be a reliable, sensitive, and specific method for the detection of the aacC3 gene in bacterial cell-free lysates. The fact that we were not able to detect the aacC3 gene in a Dutch collection of gentamicin-resistant Pseudomonas strains implies that the gene is not widespread in our region.
